Your session is about to expire
← Back to Search
SIT for Sedentary Lifestyle
N/A
Waitlist Available
Led By Michael B Dial
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks after data completion
Awards & highlights
Study Summary
This trial is testing whether exercising after sitting all day has the same effect on blood sugar levels as just sitting, and whether either of those is better than being active all day.
Eligible Conditions
- Sedentary Lifestyle
- Insulin Sensitivity
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 weeks after data completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks after data completion
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Insulin sensitivity
Trial Design
3Treatment groups
Experimental Treatment
Group I: SIT+EXExperimental Treatment2 Interventions
Subject will be asked to take <3,000 steps for two intervention days. On the evening of the second intervention day, the subject will cycle for one hour at 65% of VO2peak. The subject will undergo an oral glucose tolerance test on the morning of the third day.
Group II: SITExperimental Treatment1 Intervention
Subject will be asked to take <3,000 steps for two intervention days prior to an oral glucose tolerance test on the third day.
Group III: ACTIVE+EXExperimental Treatment2 Interventions
Subject will be asked to take >10,000 steps for two intervention days. On the evening of the second intervention day, the subject will cycle for one hour at 65% of VO2peak. The subject will undergo an oral glucose tolerance test on the morning of the third day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ACTIVE
2012
Completed Phase 2
~490
EX
2009
Completed Early Phase 1
~130
SIT
2020
N/A
~70
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
349 Previous Clinical Trials
80,372 Total Patients Enrolled
Michael B DialPrincipal InvestigatorUniversity of Texas at Austin
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger